CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Machine Learning is Impacting Clinical Trials

How Machine Learning is Impacting...

Clasado Biosciences Joins Lucie Nagy as Head of Regulatory and Legal

Clasado Biosciences Joins Lucie Nagy...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

Major Challenges Facing Life Science and Pharmaceutical Supply Chains

Major Challenges Facing Life Science...

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

The Importance of Bioanalytical Method Validation

The Importance of Bioanalytical...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

How New Regulations are Impacting the Life Science Sector

How New Regulations are Impacting the...

How Machine Learning is Impacting Clinical Trials

How Machine Learning is Impacting...

Clasado Biosciences Joins Lucie Nagy as Head of Regulatory and Legal

Clasado Biosciences Joins Lucie Nagy...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

Major Challenges Facing Life Science and Pharmaceutical Supply Chains

Major Challenges Facing Life Science...

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

The Importance of Bioanalytical Method Validation

The Importance of Bioanalytical...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

How New Regulations are Impacting the Life Science Sector

How New Regulations are Impacting the...

Syneos Health and Science 37 Announce Strategic Partnership

Life Sciences Review | Thursday, May 19, 2022
Tweet

Science 37 and Syneos Health will work together to provide biopharmaceutical companies with a single, streamlined technology framework for workflow orchestration, real-world evidence generation, and data harmonization.


FREMONT, CA: Syneos Health, the only fully integrated biopharmaceutical solutions company, and Science 37, the industry’s Decentralized Clinical Trial Operating System, announced a strategic partnership to enable enhanced decentralized clinical trial delivery. Science 37 and Syneos Health will work together to provide biopharmaceutical companies with a single, streamlined technology framework for workflow orchestration, real-world evidence generation, and data harmonization.


“Increasing clinical trial access and diversity is a scientific, business and ethical imperative as we continually look for ways to improve patient outcomes and eliminate healthcare disparities,” said Alistair Macdonald, Chief Executive Officer, Syneos Health. “Our powerful partnership with Science 37 adds their industry-leading platform to our Decentralized Solutions and, when combined with the mobile research nursing capabilities delivered through our Illingworth Research team, we’re able to open new pathways toward the long-sought goal of placing patients at the center of clinical research.”


Decentralized trials have been on the rise as companies look for new ways to improve performance, cut costs, and get trials closer to patients. These experiments, made possible by digital technology, provide:


New ways to reach more diversity.


Representative patient groups.


Reduce the burden and increase access for patients who could not previously participate in clinical trial research


Syneos Health’s Decentralized Solutions incorporates deep behavioral and therapeutic perspectives, agile technology, and organizational excellence to put clinical trials closer to patients and transform product growth. Through its open, on-demand network of patient groups, telemedicine investigators, mobile nurses, remote coordinators, and connected devices, Science 37’s premier technology platform allows virtual clinical trials, improving clinical and real-world efficacy, and yielding high-quality data collection.


“Partnering with Syneos Health extends our mission to accelerate research and enable universal patient and provider access with one of the world’s most prolific providers of clinical research services,” said David Coman, Chief Executive Officer, Science 37. “Our technology will empower the Syneos Health decentralized trial workflow, and our full Operating System will enable access to our patient communities, telemedicine investigators, and remote coordinator networks to harmonize and deliver complex decentralized clinical and real-world studies.”


The Syneos Health Dynamic Assembly network includes Science 37. Dynamic Assembly is a collaborative network of best-in-class data and technology partners dedicated to providing fit-for-purpose solutions that strategically resolve the complexities of each customer interaction. Syneos Health joins the Science 37 CRO Certified program, which provides access, preparation, and commercial support to CROs so they can successfully execute decentralized clinical studies at scale.


Weekly Brief

loading
Top 10 Bioanalytical Services Companies in Apac - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/syneos-health-and-science-37-announce-strategic-partnership-nwid-339.html